Company profile

Alibion AG

Our goal is to bring to the market the first oral, personalized therapy against Rheumatoid arthritis. We are developing the first drug potentially capable of reversing inflammation and bone erosion in a very well defined population of patients.

Alibion AG

Source: startup.ch

More news about Alibion AG

05.01.2021 14:12

Alibion ceases operations
  • Setback
    Please login or
    register to use the
    awards follow feature
    19.05.2020 17:06

    Eleven Swiss start-ups on the virtual BIO Digital stage
  • Support
    Please login or
    register to use the
    awards follow feature
    04.10.2019 12:05

    A new cohort joins the BaseLaunch accelerator
  • Financing
  • Support
    Please login or
    register to use the
    awards follow feature
    09.04.2019 09:00

    Alibion kicks off pre-clinical studies to address Rheumatoid arthritis
  • Financing
    Please login or
    register to use the
    awards follow feature
    Alibion AG

    Founded
    2018

    Kanton
    BL

    Homepage

    rss